About this test
Detects NTRK1, NTRK2 and NTRK3 gene fusions, which make tumours of any type eligible for TRK inhibitors.
- Clinical area
- Molecular oncology
- Method
- RT-PCR
- Sample
- FFPE tissue block
- Report languages
- EN · AR · RU
When to order
Advanced solid tumours without another targetable driver, and rare tumours in which NTRK fusions are common.
Results are reported to the ordering physician and should be interpreted in clinical context.
Request this test
Offer this test to your patients.
Contract pricing and turnaround times are provided on request for laboratories and clinics.
Molecular oncology